Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published April 2026 · Last reviewed May 2026
Episode 68 · The Med Device Cyber Podcast · with Michael Branagan Harris, HealthTech Strategies · April 30, 2026 In this episode of The Med Device Cyber Podcast, host Christian Espinosa and guest Michael Branagan Harris of HealthTech Strategies delve into the intricate world of market access for medical devices, emphasizing that regulatory approval is merely the first step. Michael, with 37 years of experience in MedTech, highlights the critical importance of solving healthcare problems rather than just selling products. He introduces two key frameworks: the 4 Ps of Market Access (Patient, Provider, Payer, Product) and the 5 Ps for the United States, which adds “Physician” due to the unique revenue generation models. The discussion traverses the differing economic models of healthcare systems in the UK, US, and Germany, explaining how these influence market access strategies and product viability. Michael also stresses the necessity of robust clinical and economic evidence, including real-world data and patient-reported outcomes, to demonstrate value and secure reimbursement. The episode touches on the challenges of an evolving regulatory landscape, such as the EUMDR, and the emerging role of digital health and remote patient monitoring, offering a comprehensive look at what it truly takes for MedTech innovators to achieve success beyond just product approval.
Key Takeaways
- Medical device companies must focus on solving healthcare problems rather than simply selling products to achieve market success.
- Market access strategies need to consider the unique economic models of different healthcare systems, as priorities for reimbursement and adoption vary significantly between countries like the US, UK, and Germany.
- Developing strong clinical and economic evidence, including real-world data and patient-reported outcomes, is crucial for demonstrating value and securing reimbursement from payers and providers.
- Understanding and catering to the
- 4 Ps of Market Access (Patient, Provider, Payer, Product) or 5 Ps (adding Physician for the US) is essential for a comprehensive market entry strategy.
- The US market, despite its high costs, is often the preferred initial launch market for MedTech innovators due to its established investment and revenue-generating potential.
- Digital health technologies, including remote patient monitoring and telemedicine, represent a significant area for growth and innovation, though reimbursement mechanisms for these still vary widely across regions.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.